Synthesis and antitumor activity of ureas containing pyrimidinyl group

European Journal of Medicinal Chemistry

Volumn 46, Issue 1, 2011, Pages 429-432

  Jin, Chuanfei ^a   Liang, Yong Ju ^b   He, Hongwu ^a   Fu, Liwu ^b  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

4,6 Dimethy 2 (methylsulfonyl)pyrimidine; Cytotoxicity; Urea

Indexed keywords

1 (2,4 DICHLOROPHENYL) 3 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLOXY)PHENYL)UREA; 1 (2,4 DICHLOROPHENYL) 3 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLTHIO)PHENYL)UREA; 1 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLOXY)PHENYL) 3 (4 (TRIFLUOROMETHOXY)PHENYL)UREA; 1 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLOXY)PHENYL) 3 (4 FLUOROPHENYL)UREA; 1 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLOXY)PHENYL) 3 M TOLYLUREA; 1 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLOXY)PHENYL) 3 PHENYLUREA; 1 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLTHIO)PHENYL) 3 (4 (TRIFLUOROMETHOXY)PHENYL)UREA; 1 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLTHIO)PHENYL) 3 (4 FLUOROPHENYL)UREA; 1 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLTHIO)PHENYL) 3 M TOLYLUREA; 1 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLTHIO)PHENYL) 3 PHENYLUREA; 1 (4 CHLOROPHENYL) 3 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLOXY)PHENYL)UREA; 1 (4 CHLOROPHENYL) 3 (4 (4,6 DIMETHYLPYRIMIDIN 2 YLTHIO)PHENYL)UREA; 4 (4,6 DIMETHYLPYRIMIDIN 2 YLOXY)BENZENAMINE; 4 (4,6 DIMETHYLPYRIMIDIN 2 YLTHIO)BENZENAMINE; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; UREA;

EID: 78650514778     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.11.026     Document Type: Article

References (15)

1. C.T. Gnewuch, and G. Sosnovsky Chem. Rev. 97 1997 829 1013
2. S. Liu, A.M. Crider, C. Tang, B. Ho, M. Ankersen, and C.E. Stidsen J. Med. Chem. 41 1998 4693 4705
3. J. Legault, J.F. Gaulin, E. Mounetou, N. Ritchot, J. Lacroix, P. Poyet, and C.R. Gaudreault Cancer Res. 60 2000 985 992
4. J. Easmon, G. Purstinger, G. Heinisch, T. Roth, H.H. Fiebig, W. Holzer, W. Jager, M. Jenny, and J. Hofmann J. Med. Chem. 44 2001 2164 2171
5. Y. Dai, K. Hartandi, Z. Ji, A.A. Ahmed, D.H. Albert, L. Arnold, S.S. Arries, T. Barlozzari, J.L. Bauch, J.J. Bouska, P.F. Bousquet, G.A. Cunha, K.B. Glaser, J. Guo, J. Li, P.A. Marcotte, K.C. Marsh, M.D. Moskey, L.J. Pease, K.D. Stewart, V.S. Stoll, P. Tapang, N. Wishart, S.K. Davidsen, and M.R. Michaelides J. Med. Chem. 50 2007 1584 1597
6. R.A. Smith, V. Cokkinides, and O.W. Brawley CA Cancer J. Clin. 59 2009 27 41
7. A.M. Jordan, T.H. Khan, H. Malkin, and H.M. Osborn Bioorg. Med. Chem. 10 2002 2625 2633
8. S. Wilhelm, C. Carter, M. Lynch, T. Lowinger, J. Dumas, R.A. Smith, B. Schwartz, R. Simantov, and S. Kelley Nat. Rev. Drug Discov. 5 2006 835 844
9. L.M. Lima, and E.J. Barreiro Curr. Med. Chem. 12 2005 23 49
10. S.J. Tangeda, and A. Garlapati Eur. J. Med. Chem. 45 2010 1453 1458
11. C. Mugnaini, E. Petricci, M. Botta, F. Corelli, P. Mastromarino, and G. Giorgi Eur. J. Med. Chem. 42 2007 256 262
12. D. Raffa, M.C. Edler, G. Daidone, B. Maggio, M. Merickech, S. Plescia, D. Schillaci, R. Bai, and E. Hamel Eur. J. Med. Chem. 39 2004 299 304
13. H. Okada, T. Koyanagi, N. Yamada, and T. Haga Chem. Pharm. Bull. 39 1991 2308 2315
14. E. Sturm, J.J. Gallay, and G. Pissiotas The Barbituric-acid derivatives 1986 191474
15. T. Mosmann J. Immunol. Methods 65 1983 55 63